New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

by Mary Philip and Michael Rudloff,The ConversationThis microscopy image shows a cytotoxic T cell (blue) attacking a cancer cell (green) by releasing toxic chemicals (red). Credit:Alex Rit

Updated on: January 12,2024

New research: Immune cells that fight cancer become exhausted within hours of first encountering tumors

by Mary Philip and Michael Rudloff,The ConversationThis microscopy image shows a cytotoxic T cell (blue) attacking a cancer cell (green) by releasing toxic chemicals (red). Credit:Alex Rit

Updated on:January 12,2024

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Updated on: May 31,2024

Studies give new insights on immunotherapy in elderly patients with advanced NSCLC

by European Society for Medical OncologyTwo studies to be reported at ELCC 2019 provide new insights on the efficacy and safety of immunotherapy in elderly patients with advanced non-small-cell l

Updated on:May 31,2024

Researchers develop new marker for cancer cell motility

by Leipzig UniversityTwo aggregate states of cancer cell clusters. In blue: densely packed, more rounded cancer cells jam together and cannot move, reducing the risk of metastasis. In green: more

Updated on: February 18,2024

Researchers develop new marker for cancer cell motility

by Leipzig UniversityTwo aggregate states of cancer cell clusters. In blue: densely packed, more rounded cancer cells jam together and cannot move, reducing the risk of metastasis. In green: more

Updated on:February 18,2024

Study suggests tumor mutational load may be useful metric to predict response to checkpoint-inhibitor immunotherapy

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA large team of researchers affiliated with Sloan Kettering Cancer Center, Weill Cornell Medical Center and Columbia University Medical Center has

Updated on: March 08,2024

Study suggests tumor mutational load may be useful metric to predict response to checkpoint-inhibitor immunotherapy

by Bob Yirka , Medical XpressCredit: CC0 Public DomainA large team of researchers affiliated with Sloan Kettering Cancer Center, Weill Cornell Medical Center and Columbia University Medical Center has

Updated on:March 08,2024

Researchers discover how malignant melanoma eludes immune cells

by Alan Dove,Columbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.014Malignant melanoma, a dangerous type of skin cancer, deploys an elegan

Updated on: February 03,2024

Researchers discover how malignant melanoma eludes immune cells

by Alan Dove,Columbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.05.014Malignant melanoma, a dangerous type of skin cancer, deploys an elegan

Updated on:February 03,2024

Tumor resistance is promoted by anti-cancer protein

by Champalimaud Centre for the UnknownCredit: CC0 Public DomainLack of oxygen, or hypoxia, is a biological stressor that occurs under various conditions such as wound healing and stroke. To rescue the

Updated on: April 09,2024

Tumor resistance is promoted by anti-cancer protein

by Champalimaud Centre for the UnknownCredit: CC0 Public DomainLack of oxygen, or hypoxia, is a biological stressor that occurs under various conditions such as wound healing and stroke. To rescue the

Updated on:April 09,2024

Drug that blocks blood vessel growth could treat rare sarcomas

by Institute of Cancer ResearchImage: Alveolar Soft Part Sarcoma. Credit: Michael Bonert.Licence: CC BY-SA 3.0An experimental targeted drug could treat a rare type of cancer usually affecti

Updated on: April 01,2024

Drug that blocks blood vessel growth could treat rare sarcomas

by Institute of Cancer ResearchImage: Alveolar Soft Part Sarcoma. Credit: Michael Bonert.Licence: CC BY-SA 3.0An experimental targeted drug could treat a rare type of cancer usually affecti

Updated on:April 01,2024

Breast cancer researchers find bacteria imbalance link

by Cleveland ClinicCharis Eng, M.D., Ph.D., chair of the Cleveland Clinic's Genomic Medicine Institute. Credit: Cleveland ClinicResearchers in the United States have uncovered differences in

Updated on: June 15,2024

Breast cancer researchers find bacteria imbalance link

by Cleveland ClinicCharis Eng, M.D., Ph.D., chair of the Cleveland Clinic's Genomic Medicine Institute. Credit: Cleveland ClinicResearchers in the United States have uncovered differences in

Updated on:June 15,2024

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on: January 16,2024

Lung cancer screening more cost effective when using risk model-based strategies, study shows

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainRisk model-based lung cancer screening strategies, which select individuals based on personal risk, are more co

Updated on:January 16,2024

Hypnosis may help reduce distress of cancer treatment in children

by University of ExeterHypnosis may help reduce the distress of cancer treatment in children. Credit: University of ExeterHypnosis could help to reduce the fear of medical procedures in children

Updated on: March 01,2024

Hypnosis may help reduce distress of cancer treatment in children

by University of ExeterHypnosis may help reduce the distress of cancer treatment in children. Credit: University of ExeterHypnosis could help to reduce the fear of medical procedures in children

Updated on:March 01,2024

Glioma subtypes determine how the dangerous tumors spread, evade anti-angiogenic treatment

by Massachusetts General HospitalTumorous glial cells, labeled in green, have overtaken most of an adult fly brain. Glial cell nuclei are shown in red. Credit: Courtesy of Dr. Renee Read, Salk In

Updated on: March 01,2024

Glioma subtypes determine how the dangerous tumors spread, evade anti-angiogenic treatment

by Massachusetts General HospitalTumorous glial cells, labeled in green, have overtaken most of an adult fly brain. Glial cell nuclei are shown in red. Credit: Courtesy of Dr. Renee Read, Salk In

Updated on:March 01,2024

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on: March 06,2024

Fred Hutch researchers engineer complex immunotherapy that may target relapsing leukemia

by Fred Hutchinson Cancer Research CenterDr. Marie Bleakley, a pediatric oncologist and researcher at Fred Hutch, is advancing a new approach to genetically engineer T cells. Credit: Fred HutchOc

Updated on:March 06,2024